May 19, 2004 Dear SJ Strategic Investments LLC:Columbia Laboratories Inc • May 20th, 2004 • Pharmaceutical preparations • New York
This letter sets forth the agreement of SJ Strategic Investments LLC (“Purchaser”) and Columbia Laboratories, Inc. (the “Company”) regarding the purchase by the Purchaser from the Company of an aggregate of two million (2,000,000) shares (the “Shares”) of the Company’s common stock, par value $.01 per share (the “Common Stock”) on the date hereof.
